IBD models

Gut virome in inflammatory bowel disease and beyond
Hein Min Tun, Ye Peng, Luca Massimino, Zhen Ye Sin, Tommaso Lorenzo Parigi, Amanda Facoetti, Shaila Rahman, Silvio Danese, Federica Ungaro

Gut Feb 2024, 73 (2) 350-360; DOI: 10.1136/gutjnl-2023-330001
Epithelial organoid cultures from patients with ulcerative colitis and Crohn's disease: a truly long-term model to study the molecular basis for inflammatory bowel disease?
Manuel Noben, Bram Verstockt, Magali de Bruyn, Nikolai Hendriks, Gert Van Assche, Séverine Vermeire, Catherine Verfaillie, Marc Ferrante

Gut Dec 2017, 66 (12) 2193-2195; DOI: 10.1136/gutjnl-2016-313667
Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism
I Oancea, R Movva, I Das, D Aguirre de Cárcer, V Schreiber, Y Yang, A Purdon, B Harrington, M Proctor, R Wang, Y Sheng, M Lobb, R Lourie, P Ó Cuív, J A Duley, J Begun, T H J Florin

Gut Jan 2017, 66 (1) 59-69; DOI: 10.1136/gutjnl-2015-310874
A novel myokine, secreted protein acidic and rich in cysteine (SPARC), suppresses colon tumorigenesis via regular exercise
Wataru Aoi, Yuji Naito, Tomohisa Takagi, Yuko Tanimura, Yoshikazu Takanami, Yukari Kawai, Kunihiro Sakuma, Liu Po Hang, Katsura Mizushima, Yasuko Hirai, Ryota Koyama, Sayori Wada, Akane Higashi, Satoshi Kokura, Hiroshi Ichikawa, Toshikazu Yoshikawa

Gut Jun 2013, 62 (6) 882-889; DOI: 10.1136/gutjnl-2011-300776
Ceramide-CD300f binding suppresses experimental colitis by inhibiting ATP-mediated mast cell activation
Toshihiro Matsukawa, Kumi Izawa, Masamichi Isobe, Mariko Takahashi, Akie Maehara, Yoshinori Yamanishi, Ayako Kaitani, Ko Okumura, Takanori Teshima, Toshio Kitamura, Jiro Kitaura

Gut May 2016, 65 (5) 777-787; DOI: 10.1136/gutjnl-2014-308900
A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
Paul J Rutgeerts, Richard N Fedorak, Daan W Hommes, Andreas Sturm, Daniel C Baumgart, Brian Bressler, Stefan Schreiber, John C Mansfield, Marna Williams, Meina Tang, Jennifer Visich, Xiaohui Wei, Mary Keir, Diana Luca, Dimitri Danilenko, Jackson Egen, Sharon O'Byrne

Gut Aug 2013, 62 (8) 1122-1130; DOI: 10.1136/gutjnl-2011-301769
Stromal cell-derived factor-1 overexpression induces gastric dysplasia through expansion of stromal myofibroblasts and epithelial progenitors
Wataru Shibata, Hiroshi Ariyama, Christoph Benedikt Westphalen, Daniel L Worthley, Sureshkumar Muthupalani, Samuel Asfaha, Zinaida Dubeykovskaya, Michael Quante, James G Fox, Timothy C Wang

Gut Feb 2013, 62 (2) 192-200; DOI: 10.1136/gutjnl-2011-301824
Drug development in IBD: from novel target identification to early clinical trials
Silvio Danese, Claudio Fiocchi, Julián Panés

Gut Aug 2016, 65 (8) 1233-1239; DOI: 10.1136/gutjnl-2016-311717
Defining dysbiosis threatens Koch's postulates and current dogma on the role of Paneth cells in Crohn's disease
Mathias Chamaillard, Katarina Radulovic

Gut Feb 2016, 65 (2) 190-191; DOI: 10.1136/gutjnl-2015-309714
An intestinal arsonist: pathobiont ignites IBD and flees the scene
Stefan Jellbauer, Manuela Raffatellu

Gut Jul 2014, 63 (7) 1034-1035; DOI: 10.1136/gutjnl-2013-305589

Main menu

IBD models

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

IBD models

Pages